reglab/housing_qa huggingface dataset:
CO Code § 10-16-1309 (2021)
2021 Colorado Code|Title 10 - Insurance|Article 16 - Health Care Coverage|Part 13 - Colorado Standardized Health Benefit Plan|§ 10-16-1309. Standardized Plan - Cost Shift

  If the administrator of a self-funded health insurance plan voluntarily provides to the commissioner its contracted rates and any other information deemed necessary and agreed upon by the administrator and the commissioner, the commissioner may evaluate whether the rates of the self-funded health insurance plan reflect a cost shift between the self-funded plan and the standardized plan offered by a carrier pursuant to section 10-16-1305.    If the commissioner determines there is a cost shift, the commissioner shall, to the extent practicable, provide a description of which categories of services have experienced the greatest cost shift to the administrator of the self-funded health insurance plan.     History. Source: L. 2021: Entire part added,(HB 21-1232), ch. 241, p. 1291, § 1, effective June 16.
CO Code § 10-16-1310 (2021)
2021 Colorado Code|Title 10 - Insurance|Article 16 - Health Care Coverage|Part 13 - Colorado Standardized Health Benefit Plan|§ 10-16-1310. Reports Required - Repeal

     The commissioner shall contract with an independent third-party organization to prepare three separate reports as specified in subsection (1)(d) of this section, to the extent that information is available regarding the implementation of this part 13 as it relates to the staffing, wages, benefits, training, and working conditions of hospital workers.    In choosing an independent third-party contractor, the commissioner shall consider organizations with experience conducting in-person interviews with health-care employers and employees in Colorado.    The independent third-party contractor may make policy recommendations related to information in the reports and may include data collected from employers, employees, and other third-party sources.    The independent third-party contractor shall deliver the reports to the commissioner as follows:   The first report by July 1, 2023;    The second report by July 1, 2024; and    The third report by July 1, 2025.          The commissioner shall monitor whether there are an adequate number of health-care providers in the carriers' standardized plan network and the percentage of premiums attributable to health-care providers in the network. As part of the rate and form filing required pursuant to section 10-16-107, each carrier shall provide to the commissioner information on whether there are an adequate number of health-care providers in the carrier's standardized plan network and the reduction in premiums as a result of health-care provider participation in the network.      The commissioner shall contract with an independent third-party organization to evaluate how to phase in, to the extent practicable, to a hospital's reimbursement rate methodology described in section 10-16-1306:   A quality metric adjustment; and    An acuity adjustment as measured by a hospital's case-mix index.       The evaluation must be completed by December 31, 2022.       This section is repealed, effective July 1, 2026.      History. Source: L. 2021: Entire part added,(HB 21-1232), ch. 241, p. 1291, § 1, effective June 16.
CO Code § 10-16-1311 (2021)
2021 Colorado Code|Title 10 - Insurance|Article 16 - Health Care Coverage|Part 13 - Colorado Standardized Health Benefit Plan|§ 10-16-1311. State Measurement for Accountable, Responsive, and Transparent (Smart) Government Act Report

  The commissioner shall report during the hearings conducted pursuant to the “State Measurement for Accountable, Responsive, and Transparent (SMART) Government Act”, part 2 of article 7 of title 2:   Beginning in January 2022 and each year thereafter, on the progress of the implementation and operation of this part 13, including the information collected pursuant to section 10-16-1310 (2);    Beginning in January 2024, and each year thereafter, on the carriers' efforts to develop networks that are diverse and culturally responsive pursuant to section 10-16-1304 (1)(g) and the carriers' efforts required by section 10-16-1304 (2); and    In January 2024, January 2025, and January 2026, on the results of the reports required in section 10-16-1310.        History. Source: L. 2021: Entire part added,(HB 21-1232), ch. 241, p. 1292, § 1, effective June 16.
CO Code § 10-16-1312 (2021)
2021 Colorado Code|Title 10 - Insurance|Article 16 - Health Care Coverage|Part 13 - Colorado Standardized Health Benefit Plan|§ 10-16-1312. Rules

 The commissioner may promulgate rules as necessary to develop, implement, and operate this part 13, including rules necessary to align state law with any federal program requirements and applicable rules.   History. Source: L. 2021: Entire part added,(HB 21-1232), ch. 241, p. 1293, § 1, effective June 16.
CO Code § 10-16-1313 (2021)
2021 Colorado Code|Title 10 - Insurance|Article 16 - Health Care Coverage|Part 13 - Colorado Standardized Health Benefit Plan|§ 10-16-1313. Severability

 If any provision of this part 13 or application thereof to any person or circumstances is judged invalid, the invalidity does not affect provisions or applications of this part 13 that can be given effect without the invalid provision or application, and to this end the provisions of this part 13 are declared severable.   History. Source: L. 2021: Entire part added,(HB 21-1232), ch. 241, p. 1293, § 1, effective June 16.
CO Code § 10-16-1403 (2021)
2021 Colorado Code|Title 10 - Insurance|Article 16 - Health Care Coverage|Part 14 - Colorado Prescription Drug Affordability Review Board|§ 10-16-1403. Colorado Prescription Drug Affordability Review Board - Powers and Duties - Rules

  To protect Colorado consumers from excessive prescription drug costs, the board shall:   Collect and evaluate information concerning the cost of prescription drugs sold to Colorado consumers, as described in section 10-16-1405;    Perform affordability reviews of prescription drugs, as described in section 10-16-1406;    Establish upper payment limits for prescription drugs, as described in section 10-16-1407; and    Make policy recommendations to the general assembly to improve the affordability of prescription drugs for Colorado consumers, as described in section 10-16-1414 (1)(h).       The board may establish ad hoc work groups to consider matters related to the work of the board pursuant to this part 14. Ad hoc work groups may include members of the public.    The division, on behalf of the board, may enter into a contract with a qualified, independent third party for any service necessary to carry out the powers and duties of the board. A third party with which the division contracts pursuant to this subsection (3), including any of the third party's directors, officers, employees, contractors, or agents, shall not release or publish any information that the third party acquires pursuant to its performance under the contract. Any third party with which the division contracts pursuant to this subsection (3) shall disclose any conflict of interest to the board.    In carrying out its duties pursuant to this part 14, the division, when performing its duties on behalf of the board, is exempt from the state “Procurement Code”, articles 101 to 112 of title 24.    The board shall promulgate rules as necessary, pursuant to article 4 of title 24, for the implementation of this part 14.      The division, on behalf of the board, may seek, accept, and expend gifts, grants, and donations from private or public sources for the purposes of this part 14, and any such gifts, grants, and donations are continuously appropriated to the department of regulatory agencies; except that the division shall not accept any gift, grant, or donation that creates a conflict of interest or the appearance of any conflict of interest for any board member.    The general assembly finds that the implementation of this part 14 does not rely entirely on the receipt of adequate funding through gifts, grants, or donations. Therefore, the board is not subject to the reporting requirements described in section 24-75-1303.         History. Source: L. 2021: Entire part added,(SB 21-175), ch. 240, p. 1261, § 2, effective June 16.
CO Code § 10-16-1404 (2021)
2021 Colorado Code|Title 10 - Insurance|Article 16 - Health Care Coverage|Part 14 - Colorado Prescription Drug Affordability Review Board|§ 10-16-1404. Colorado Prescription Drug Affordability Review Board Meetings - Required to Be Public - Exceptions

  The board shall hold its first meeting within six weeks after all of the board members are appointed and shall meet at least every six weeks thereafter to review prescription drugs; except that the chair may cancel or postpone a meeting if the board has no prescription drugs to review.    The board is a state public body for purposes of section 24-6-402, and the board's meetings and the meetings of ad hoc work groups of the board are public meetings.    The board shall meet in executive session to discuss proprietary information. The board and any board members, officers, directors, employees, contractors, and agents shall not disclose or otherwise make available to the public any materials or information containing trade-secret, confidential, or proprietary data that is not otherwise available to the public. Electronic recordings of such executive sessions are not permitted if they would result in the disclosure of any materials or information containing trade-secret, confidential, or proprietary data, and in no case shall minutes from such executive sessions disclose or include materials or information containing trade-secret, confidential, or proprietary data. The board shall not take any of the following actions while meeting in executive session:   Deliberations concerning whether to subject a prescription drug to an affordability review as described in section 10-16-1406;    Votes concerning whether to establish an upper payment limit on a prescription drug; or    Any final decision of the board.        History. Source: L. 2021: Entire part added,(SB 21-175), ch. 240, p. 1262, § 2, effective June 16.
CO Code § 10-16-1408 (2021)
2021 Colorado Code|Title 10 - Insurance|Article 16 - Health Care Coverage|Part 14 - Colorado Prescription Drug Affordability Review Board|§ 10-16-1408. Colorado Prescription Drug Affordability Review Board - Appeals - Rules - Judicial Review

  A person aggrieved by a decision of the board may appeal the decision within sixty days after the decision is made. The board shall consider the appeal and issue a final decision concerning the appeal within sixty days after the board receives the appeal.    Not later than March 31, 2022, the board shall promulgate rules establishing a process and timeline for the consideration by the board of any appeal that is submitted to the board pursuant to subsection (1) of this section. The process and timeline must comport with the “State Administrative Procedure Act”, article 4 of title 24.    In the absence of an appeal, a decision of the board becomes final and ripe for judicial review after sixty days. Any person aggrieved by a final decision of the board may petition for judicial review pursuant to section 24-4-106.    Notwithstanding any provision of law to the contrary:   An individual may request an expedited review, as described in section 10-16-113.5, of access to a prescription drug that is unavailable to the individual because a manufacturer refuses to make the drug available as a result of an upper payment limit established for the prescription drug by the board; and    A carrier may disregard the upper payment limit if the independent external review entity that performs the expedited review determines pursuant to such review that the prescription drug should be covered for and available to that individual.        History. Source: L. 2021: Entire part added,(SB 21-175), ch. 240, p. 1270, § 2, effective June 16.
CO Code § 10-16-1410 (2021)
2021 Colorado Code|Title 10 - Insurance|Article 16 - Health Care Coverage|Part 14 - Colorado Prescription Drug Affordability Review Board|§ 10-16-1410. Use of Savings - Report - Rules

  Any savings generated for a health benefit plan that are attributable to the establishment of an upper payment limit established by the board pursuant to section 10-16-1407 must be used by the carrier that issues the health benefit plan to reduce costs to consumers, prioritizing the reduction of out-of-pocket costs for prescription drugs.    On or before March 15, 2023, and on or before March 15 each year thereafter, each state entity and each carrier that issues a health benefit plan or optional participating plan shall submit to the board a report describing the savings achieved during the preceding plan year for each prescription drug for which the board established an upper payment limit during the preceding year and how those savings were used to satisfy the requirement described in subsection (1) of this section.    On or before November 1, 2022, the board shall promulgate rules establishing a formula for calculating savings for the purpose of complying with subsection (1) of this section.     History. Source: L. 2021: Entire part added,(SB 21-175), ch. 240, p. 1273, § 2, effective June 16.
CO Code § 10-16-1411 (2021)
2021 Colorado Code|Title 10 - Insurance|Article 16 - Health Care Coverage|Part 14 - Colorado Prescription Drug Affordability Review Board|§ 10-16-1411. Unlawful Acts - Enforcement - Penalties

  On and after January 1, 2022, it is unlawful for any person to purchase or reimburse a payer for a prescription drug for which the board has established an upper payment limit pursuant to section 10-16-1407 at an amount that exceeds the upper payment limit established by the board for that prescription drug, regardless of whether the prescription drug is dispensed or distributed in person, by mail, or by other means.    On and after January 1, 2023, each state entity, carrier, and optional participating plan shall require compliance with an upper payment limit established by the board.    The attorney general is authorized to enforce this part 14 on behalf of any state entity or any consumer of prescription drugs.    Notwithstanding any provision of this part 14 to the contrary, as used in this section, “person” does not include an individual who acquires a prescription drug for the individual's own use or for a family member's use.    Notwithstanding any provision of this section to the contrary, a carrier or state agency that is required pursuant to state or federal law to purchase or reimburse a payer for a prescription drug for which the board has established an upper payment limit pursuant to section 10-16-1407 is not subject to an enforcement action for a violation of subsection (1) or (2) of this section for that particular prescription drug.     History. Source: L. 2021: Entire part added,(SB 21-175), ch. 240, p. 1273, § 2, effective June 16.
CO Code § 10-16-1412 (2021)
2021 Colorado Code|Title 10 - Insurance|Article 16 - Health Care Coverage|Part 14 - Colorado Prescription Drug Affordability Review Board|§ 10-16-1412. Notice of Withdrawal of Prescription Drugs With Upper Payment Limits Required - Rules - Penalty

  Any manufacturer that intends to withdraw from sale or distribution within the state a prescription drug for which the board has established an upper payment limit pursuant to section 10-16-1407 shall provide a notice of withdrawal in writing at least one hundred eighty days before the withdrawal to:   The commissioner;    The attorney general; and    Each entity in the state with which the manufacturer has contracted for the sale or distribution of the prescription drug.       The board shall promulgate rules to notify consumers of the intent of any manufacturer to withdraw a prescription drug from sale or distribution within the state, as described in subsection (1) of this section.    After providing notice and a hearing as described in section 24-4-105, the commissioner may require a manufacturer to pay a penalty not to exceed five hundred thousand dollars if the commissioner determines that the manufacturer failed to provide the notice required by subsection (1) of this section before withdrawing from sale or distribution within the state a prescription drug for which the board has established an upper payment limit pursuant to section 10-16-1407.     History. Source: L. 2021: Entire part added,(SB 21-175), ch. 240, p. 1274, § 2, effective June 16.
CO Code § 10-16-1413 (2021)
2021 Colorado Code|Title 10 - Insurance|Article 16 - Health Care Coverage|Part 14 - Colorado Prescription Drug Affordability Review Board|§ 10-16-1413. Optional Participating Plans - Notice of Election to Participate Required

 An optional participating plan that elects to subject its purchases of or payer reimbursements for prescription drugs in Colorado to the requirements of this part 14 shall notify the commissioner in writing within thirty days after such election.   History. Source: L. 2021: Entire part added,(SB 21-175), ch. 240, p. 1274, § 2, effective June 16.
CO Code § 10-16-1415 (2021)
2021 Colorado Code|Title 10 - Insurance|Article 16 - Health Care Coverage|Part 14 - Colorado Prescription Drug Affordability Review Board|§ 10-16-1415. Exemption - Prescription Drugs Derived From Cannabis

 Notwithstanding any provision of this part 14 to the contrary, the board has no authority to perform an affordability review of, or to establish an upper payment limit for, any prescription drug that is derived in whole or in part from cannabis.   History. Source: L. 2021: Entire part added,(SB 21-175), ch. 240, p. 1276, § 2, effective June 16.
CO Code § 10-16-1416 (2021)
2021 Colorado Code|Title 10 - Insurance|Article 16 - Health Care Coverage|Part 14 - Colorado Prescription Drug Affordability Review Board|§ 10-16-1416. Repeal of Part

 This part 14 is repealed, effective September 1, 2026. Before the repeal, the functions of the board are scheduled for review in accordance with section 24-34-104 .   History. Source: L. 2021: Entire part added,(SB 21-175), ch. 240, p. 1276, § 2, effective June 16.
CO Code § 11-51-201.5 (2021)
2021 Colorado Code|Title 11 - Financial Institutions|Article 51 - Securities|Part 2 - Definitions and References to Federal Statutes and Rules|§ 11-51-201.5. Investment Adviser Registration Depository - Definition

 As used in this article, unless the context otherwise requires:    “Investment adviser registration depository” means the electronic computer registration system known as the investment adviser registration depository, which is operated and maintained by the financial industry regulatory authority and by the states that participate in the system. The term includes any successor system.     History. Source: L. 2001: Entire section added, p. 15, § 1, effective March 9. L. 2015: Entire section amended, (SB 15-104), ch. 177, p. 576, § 3, effective May 11.
CO Code § 11-51-301 (2021)
2021 Colorado Code|Title 11 - Financial Institutions|Article 51 - Securities|Part 3 - Registration of Securities and Exemptions|§ 11-51-301. Requirement for Registration of Securities

 It is unlawful for any person to offer to sell or sell any security in this state unless it is registered under this article 51; the security or transaction is exempted under section 11-51-307 , 11-51-308 , 11-51-308 .5, or 11-51-309 ; or the security is a federal covered security for which a notice filing has been made pursuant to section 11-51-304.5 .   History. Source: L. 90: Entire article R&RE, p. 707, § 1, effective July 1. L. 2016: Entire section amended,(SB 16-189), ch. 210, p. 757, § 18, effective June 6. L. 2018: Entire section amended,(HB 18-1388), ch. 280, p. 1755, § 1, effective August 8.    Editor's note:   This section is similar to former § 11-51-107 (1) as it existed prior to 1990.   Cross references:   For the applicability of this section, see § 11-51-102 (1) and (7). For securities exempted from this section, see § 11-51-307 .   ANNOTATION   Law reviews. For article, “Criminal Prosecutions under the Colorado Securities Act”, see 47 U. Colo. L. Rev. 233 (1976).   Annotator's note. The following annotations include cases decided under former provisions similar to this section.   When all offerees have equal access to information, there is no need for registration. Lively v. Hirschfeld, 308 F. Supp. 612 (D. Colo. 1970 ).   This section and 15 U.S.C. § 77e are identical in thrust, although the wording of the federal statute is more comprehensive. People v. Terranova, 38 Colo. App. 476, 563 P.2d 363 (1976).   Only a general intent, and not scienter, need be shown under a charge of sale of unregistered securities. People v. Terranova, 38 Colo. App. 476, 563 P.2d 363 (1976).   Applied in Lowery v. Ford Hill Inv. Co., 37 Colo. App. 260, 548 P.2d 127 (1976).
CO Code § 11-51-304.5 (2021)
2021 Colorado Code|Title 11 - Financial Institutions|Article 51 - Securities|Part 3 - Registration of Securities and Exemptions|§ 11-51-304.5. Notice Filing - Investment Companies

  With respect to a security that is a federal covered security as defined in section 18 (b)(2) of the federal “Securities Act of 1933”, as amended, 15 U.S.C. sec. 77r (b)(2), that is not otherwise exempt under section 11-51-307, 11-51-308, .5, or 11-51-309, before the initial offer of the security, the issuer must file with the securities commissioner a form NF established by the North American Securities Administrators Association, or an analogous form prescribed by the securities commissioner, along with a notice filing fee, which fee shall be determined and collected pursuant to section 11-51-707.    A notice filing under this section is effective only for securities sold within twelve months after the date on which the form NF was filed with the securities commissioner. On or before the expiration date, the issuer may renew a notice filing by filing another form NF and paying a renewal fee, which fee shall be determined and collected pursuant to section 11-51-707. The renewed notice filing becomes effective upon the expiration of the filing being renewed.    If the securities commissioner finds there is a failure to comply with a notice filing or fee requirement of this section, the securities commissioner may issue a stop order suspending the offer or sale of those securities for which notice filing has not been made or the notice filing fee has not been paid. If the securities commissioner finds that a deficiency is corrected, the stop order is void and no penalty will be imposed.     History. Source: L. 2018: Entire section added, (HB 18-1388), ch. 280, p. 1756, § 3, effective August 8.
CO Code § 11-51-305 (2021)
2021 Colorado Code|Title 11 - Financial Institutions|Article 51 - Securities|Part 3 - Registration of Securities and Exemptions|§ 11-51-305. Filing of Sales Literature

  The securities commissioner may, by rule or order, require the filing of any prospectus, pamphlet, circular, form letter, advertisement, or other sales literature addressed or intended for distribution to prospective investors, unless:   The security or the transaction is exempted by section 11-51-307, 11-51-308, or 11-51-309; or    The security is subject to the filing requirements of section 11-51-304.5.        History. Source: L. 90: Entire article R&RE, p. 714, § 1, effective July 1. L. 2018: Entire section amended,(HB 18-1388), ch. 280, p. 1756, § 4, effective August 8.    Editor's note:   This section is similar to former § 11-51-114 as it existed prior to 1990.   Cross references:   For securities exempted from this section, see § 11-51-307 .   ANNOTATION   Law reviews. For article, “Criminal Prosecutions under the Colorado Securities Act”, see 47 U. Colo. L. Rev. 233 (1976).   Applied in Brooks v. Land Drilling Co., 574 F. Supp. 1050 (D. Colo. 1983 ) (decided under § 11-51-114 as it existed prior to the 1990 repeal and reenactment of this article).